International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-3 doi: 10.5281/zenodo.15684763
Original Research Article
MULTIDRUG RESISTANCE IN DIABETIC FOOT WOUNDS IN RURAL POPULATION OF SOUTH INDIA -A PROSPECTIVE STUDY
Published
May 10, 2025
Abstract

Background: Multidrug-resistant organisms (MDROs) are increasingly implicated in diabetic foot infections, particularly in rural populations, where limited healthcare resources may exacerbate the issue. This study aimed to evaluate the prevalence of MDROs in diabetic foot ulcers and assess factors influencing wound healing in a rural South Indian setting. Methods: A prospective, hospital-based observational study was conducted at Karpaga Vinayaka Institute of Medical Sciences, Tamil Nadu, from July 2024 to January 2025. A total of 85 diabetic patients with foot ulcers were enrolled. Clinical evaluations included history, physical examination, and laboratory investigations such as blood tests, chest X-ray, ECG, and wound culture and sensitivity. Patients were categorized based on the presence of MDROs and wound healing outcomes. Results: Of the 85 patients, 64.7% harbored at least one MDRO. The most common MDROs included Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Proteus mirabilis. Poor glycemic control (HbA1c > 8%) was significantly associated with the presence of MDROs (p = 0.031). Peripheral neuropathy was a significant predictor of non-healing ulcers (p = 0.007). Among patients with MDRO infections, wound healing was slower compared to those without MDROs. Conclusion: The high prevalence of MDROs in diabetic foot ulcers in rural South India highlights the need for stringent glycemic control, early intervention for neuropathy, and culture-based antibiotic therapy. These measures are crucial for improving wound healing and reducing the risk of amputation in diabetic foot patients.

Recommended Articles
Loading Image...
Volume-6, Issue-3
Citations
440 Views
163 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved